The Norwegian Multiple Sclerosis Registry and Biobank.

The Norwegian Multiple Sclerosis Registry and Biobank. Acta Neurol Scand Suppl. 2015;132(199):24-8 Authors: Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Aarseth JH Abstract Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system with unknown cause and various benefits from disease modifying therapies. Systematic recording of data into national MS registries is therefore needed to optimize treatment and define the pathogenesis of the disease. The Norwegian MS Registry and Biobank was established for systematic collection of clinical and epidemiological data, as well as biological samples. Data collection is based on informed consent from the individual patients and recordings by treating neurologists. All researchers have, by application, access to data and biological samples from the Norwegian Multiple Sclerosis Registry and Biobank. By this combined effort from both patients and healthcare personnel, the Registry and Biobank aims to facilitate research for improved understanding of disease mechanisms and improved health care in MS. PMID: 26046555 [PubMed - in process]
Source: Acta Neurologica Scandinavica. Supplementum - Category: Neurology Authors: Tags: Acta Neurol Scand Suppl Source Type: research